bortezomib - Globe Thesis

Keyword [bortezomib] Result: 1 - 20 \| Page: 1 of 10
1.	Study Of The Effect Of Proteasome Inhibitor Bortezomib On Human Pancreatic Cancer Cells
2.	Targeting Wnt Signal Pathway In The Treatment Of Multiple Myeloma
3.	Clinical Study On Bortezomib And Thalidomide In The Treatment Of Multiple Myeloma
4.	The Establishment Of Proteasome Inhibitor Bortezomib Resistant Leukemia Cell Lines And Study On Its Drug Resistance Mechanism
5.	New Strategy For Mantle Cell Lymphoma Targeted Therapy And Its Apoptotic Mechanism
6.	Effects Of Bortezomib On Osteoclastogenesis Of Patients With Multiple Myeloma And The Underlying Machanisms
7.	Synergistic Effect Of Histone Deacetylase Inhibitor SBHA With Proteasome Inhibitors Bortezomib Or MG-132 On Breast Cancer Cells
8.	Studies On The Molecular Mechanisms Of Lidamycin And Its Combination With Bortezomib Against Myeloma
9.	The Establishment Of Bortezomib Resistant Myeloma Cell Line And Study Of Its Drug Resistance Mechanism
10.	Lapatinib In Combination With Bortezomib Inhibits Breast Cancer Cells Growth And The Activity Of Bortezomib To Lapatinib-resistant Breast Cancer Cell
11.	Proteasome Inhibition By Bortezomib In The Regulation Of NK Cell Survival And Function
12.	Differential Effects Of Bortezomib On Acute Graft Versus Host Disease Mediated By Dendritic Cells
13.	The Effect And Mechanism Of Bortezomib, Arsenic Trioxide Or Their Combination On Reverse Multidrug Resistance In HL60/ADR Cells
14.	Bortezomib Sensitizes Gastric Cancer Cells To TRAIL-induced Apoptosis
15.	Reversal Of Drug Resistance In Myelogenous Leukemia By Combination Of Multiple Targeted Signal Pathway Inhibitors And Its Mechanism
16.	Autophagy Lysosomal Pathway And The Ubiquitin-proteasome Pathway Liver Cancer Drug Intervention Studies
17.	Expression Of NF-κB / P65 In Bone Marrow Biopsy Of Diffuse Large B-cell Lymphoma And Multiple Myeloma And Its Clinical Significance
18.	The Clinical Observation Of Bortezomib Used In Relapsed Or Refractory Hematologic Malignancy
19.	Effects Of Bortezomib Combined With Adriamycin On The Cell Line Of The Lymphoma
20.	Clinical Study Of New Therapy For Relapsed/refractory Multiple Myeloma
<<First <Prev Next> Last>> Jump to